Future Farm Completes Filing of 2018 Audit

Vancouver, British Columbia, July 20, 2018 (GLOBE NEWSWIRE) — Future Farm Technologies Inc. (the “Company”) (CSE: FFT) (OTCQX: FFRMF) announces that its 2018 annual audited financial statements (the “Annual FS”), related management’s discussion and analysis (the “Annual MD&A”), and CEO and CFO certifications (collectively, the “Annual Required Filings”) were filed on Wednesday, July 18, 2018.

The Company had an active year of mergers and acquisitions, which successfully expanded and diversified its portfolio of assets. This level of activity caused delays in the audit process and the completion of the Annual Required Filings, which ultimately resulted in a cease trade order (CTO) being issued by the British Columbia Securities Commission (BCSC) on July 6, 2018.  The BCSC confirms that all materials have been received and that revocation of the CTO is being processed.

“We are pleased to have completed the Annual Required Filings and thank our shareholders for their patience during the CTO. We are eager to fully return our focus to building Future Farm and value for our investors,” states Mr. William Gildea, Future Farm’s Chairman and CEO.

For further information, contact William Gildea, Director, at 617.834.9467.

On behalf of the Board,

Future Farm Technologies Inc.

William Gildea, CEO & Chairman

About Future Farm Technologies Inc.

Future Farm is a Canadian company with holdings throughout North America including California, Massachusetts, Florida, Maine, Puerto Rico and Newfoundland. The Company’s mission is to advance sustainable agriculture through production of wholesale and retail cannabis products, including hemp. As a leader in its field, Future Farm is committed to using only the highest quality processes and products. Towards this goal, the Company acquires or partners with licensed cannabis operators, and acquires or develops leading technologies in cannabis production, breeding, genetics, and Controlled Environment Agriculture (CEA). Future Farm’s scalable, indoor CEA systems utilize minimal land, water and energy resources. The Company holds an exclusive, worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, generates yields up to 10 times greater per square foot of land.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. The Canadian Securities Exchange has not in any way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release. 

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements.  There is no guarantee that the Company will complete the Arrangement, or if completed, will be listed on a stock exchange. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties.  We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

William Gildea

Primary Logo


Source: GlobeNewswire (July 20, 2018 – 8:00 AM EDT)

The post Future Farm Completes Filing of 2018 Audit appeared first on CannabisFN.

Related Posts

Previous Post Next Post

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis News Highlights
Get Free Weekly News

Subscribe and get the best cannabis news of the week delivered directly to you.

Thank you for subscribing.

Something went wrong.

Share This